Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Camilla Rodrigues

Showing results (191-200 of 246) with videos related to

Pageof 25
Sort By:
American Journal of Respiratory and Critical Care Medicine|August 13, 2011
A multisite assessment of the quantitative capabilities of the Xpert MTB/RIF assayRobert Blakemore, Pamela Nabeta, Amy L Davidow, et al.
Trials|November 8, 2014
The Global Consortium for Drug-resistant Tuberculosis Diagnostics (GCDD): design of a multi-site, head-to-head study of three rapid tests to detect extensively drug-resistant tuberculosisNaomi Hillery, Erik J Groessl, Andre Trollip, et al.
Virology|April 3, 2022
ZIKV replication is differential in explants and cells of human placental which is suppressed by HSV-2 coinfectionLauana Ribas Torres, Lyana Rodrigues Pinto Lima Capobianco, Audrien Alves Andrade de Souza, et al.
Antimicrobial Agents and Chemotherapy|November 5, 2014
Evaluation of pyrosequencing for detecting extensively drug-resistant Mycobacterium tuberculosis among clinical isolates from four high-burden countriesKanchan Ajbani, Shou-Yean Grace Lin, Camilla Rodrigues, et al.
Scientific Reports|July 8, 2024
Multi-centric evaluation of Truenat MTB and MTB-RIF Dx assays for diagnosis of extrapulmonary tuberculosisUrvashi B Singh, Manjula Singh, Camilla Rodrigues, et al.
The European Respiratory Journal|December 24, 2021
Cycloserine did not increase depression incidence or severity at standard dosing for multidrug-resistant tuberculosisJeffrey A Tornheim, Zarir F Udwadia, Prerna R Arora, et al.
Indian Journal of Critical Care Medicine : Peer-Reviewed, Official Publication of Indian Society of Critical Care Medicine|September 5, 2024
ISCCM Position Statement on the Approach to and Management of Critically Ill Patients with TuberculosisBinila Chacko, Dhruva Chaudhry, John V Peter, et al.
Plos One|September 1, 2015
Performance Comparison of Three Rapid Tests for the Diagnosis of Drug-Resistant TuberculosisAntonino Catanzaro, Timothy C Rodwell, Donald G Catanzaro, et al.
Indian Journal of Critical Care Medicine : Peer-Reviewed, Official Publication of Indian Society of Critical Care Medicine|October 16, 2024
ISCCM Position Statement on the Approach to and Management of Critically Ill Patients with TuberculosisBinila Chacko, Dhruva Chaudhry, John V Peter, et al.
Open Forum Infectious Diseases|January 31, 2022
Increased Moxifloxacin Dosing Among Patients With Multidrug-Resistant Tuberculosis With Low-Level Resistance to Moxifloxacin Did Not Improve Treatment Outcomes in a Tertiary Care Center in Mumbai, IndiaJeffrey A Tornheim, Zarir F Udwadia, Prerna R Arora, et al.
Pageof 25

Showing results (191-200 of 246) with videos related to

Sort By:
Pageof 25
American Journal of Respiratory and Critical Care Medicine|August 13, 2011
A multisite assessment of the quantitative capabilities of the Xpert MTB/RIF assayRobert Blakemore, Pamela Nabeta, Amy L Davidow, et al.
Trials|November 8, 2014
The Global Consortium for Drug-resistant Tuberculosis Diagnostics (GCDD): design of a multi-site, head-to-head study of three rapid tests to detect extensively drug-resistant tuberculosisNaomi Hillery, Erik J Groessl, Andre Trollip, et al.
Virology|April 3, 2022
ZIKV replication is differential in explants and cells of human placental which is suppressed by HSV-2 coinfectionLauana Ribas Torres, Lyana Rodrigues Pinto Lima Capobianco, Audrien Alves Andrade de Souza, et al.
Antimicrobial Agents and Chemotherapy|November 5, 2014
Evaluation of pyrosequencing for detecting extensively drug-resistant Mycobacterium tuberculosis among clinical isolates from four high-burden countriesKanchan Ajbani, Shou-Yean Grace Lin, Camilla Rodrigues, et al.
Scientific Reports|July 8, 2024
Multi-centric evaluation of Truenat MTB and MTB-RIF Dx assays for diagnosis of extrapulmonary tuberculosisUrvashi B Singh, Manjula Singh, Camilla Rodrigues, et al.
The European Respiratory Journal|December 24, 2021
Cycloserine did not increase depression incidence or severity at standard dosing for multidrug-resistant tuberculosisJeffrey A Tornheim, Zarir F Udwadia, Prerna R Arora, et al.
Indian Journal of Critical Care Medicine : Peer-Reviewed, Official Publication of Indian Society of Critical Care Medicine|September 5, 2024
ISCCM Position Statement on the Approach to and Management of Critically Ill Patients with TuberculosisBinila Chacko, Dhruva Chaudhry, John V Peter, et al.
Plos One|September 1, 2015
Performance Comparison of Three Rapid Tests for the Diagnosis of Drug-Resistant TuberculosisAntonino Catanzaro, Timothy C Rodwell, Donald G Catanzaro, et al.
Indian Journal of Critical Care Medicine : Peer-Reviewed, Official Publication of Indian Society of Critical Care Medicine|October 16, 2024
ISCCM Position Statement on the Approach to and Management of Critically Ill Patients with TuberculosisBinila Chacko, Dhruva Chaudhry, John V Peter, et al.
Open Forum Infectious Diseases|January 31, 2022
Increased Moxifloxacin Dosing Among Patients With Multidrug-Resistant Tuberculosis With Low-Level Resistance to Moxifloxacin Did Not Improve Treatment Outcomes in a Tertiary Care Center in Mumbai, IndiaJeffrey A Tornheim, Zarir F Udwadia, Prerna R Arora, et al.
Pageof 25